— Know what they know.
Not Investment Advice
Also trades as: KOPRAN.BO (BSE) · $vol 0M

KOPRAN.NS NSE

Kopran Limited
1W: +4.2% 1M: +29.6% 3M: +45.9% YTD: +97.4% 1Y: +81.7% 3Y: +33.8% 5Y: +39.4%
₹269.00 ($2.79)
-13.05 (-4.63%)
 
NSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 71 · ₹13.7B mcap · 23M float · 3.96% daily turnover

Cash Flow Trends

Operating Cash Flow
$566M +34.9% ▲
5Y CAGR: -1.2%
Capital Expenditures
$671M -21.2% ▼
5Y CAGR: +22.4%
Free Cash Flow
-$105M +21.6% ▲
Dividends Paid
$145M -0.2% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$128M -212.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$818M$361M$510M$386M$257M
Depreciation & Amort.$111M$127M$129M$156M$175M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$1.1B-$55M-$309M-$216M$123M
Other Non-Cash Items-$156M-$92M$103M$93M$10M
Operating Cash Flow-$335M$340M$433M$419M$566M
— Investing Activities —
Capital Expenditures-$398M-$549M-$504M-$554M-$671M
Acquisitions (Net)$0$0$605K$0$19M
Investment Purchases-$453M$0-$4M-$4M-$1M
Investment Sales$23M$4M$0$0$5M
Other Investing-$16M$418M$72M-$6M$0
Investing Cash Flow-$844M-$127M-$436M-$564M-$649M
— Financing Activities —
Net Debt Issuance$83M$7M$240M$484M$40M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$65M-$145M-$145M-$145M-$145M
Other Financing-$55M-$61M-$85M-$94M$0
Financing Cash Flow$1.2B-$198M$10M$259M-$105M
Net Change in Cash$49M$15M$7M$114M-$128M
Cash End of Period$59M$74M$81M$195M$72M
Free Cash Flow-$757M-$270M-$134M-$134M-$105M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms